透過您的圖書館登入
IP:18.222.107.172
  • 學位論文

氣管灌注B[a]P對大鼠肝臟與肺臟內雌激素氫氧化活性之比較

Intratracheal Instillation of Benzo[a]pyrene Differentially Affects Estrogen Hydroxylation in the Liver and Lung of Rats

指導教授 : 張耀仁

摘要


目前已知雌激素與其代謝物與多種癌症之形成有關,而benzo[a]pyrene (B[a]P)所活化的cytochrome P4501 (CYP1)酵素會促進17β-estradiol hydroxylation (E2 hydroxylation),其中2-hydroxyestradiol (2-OHE2)及4-hydroxyestradiol (4-OHE2)具有基因毒性。在動物實驗B[a]P會促進母鼠的肺臟腫瘤形成,為了探討B[a]P是否在肝與肺增加E2 hydroxylase酵素活性,因此本研究首先建立E2及其代謝物(2-OHE2、4-OHE2)之氣相層析質譜儀(GC/EI-MS)分析方法,用於偵測經4 mg/kg B[a]P氣管灌注處理後24小時的Sprague-Dawley (SD) 大鼠,其肝臟與肺臟內E2 2-hydroxylase與E2 4-hydroxylase之酵素活性是否上升。我們建立的分析方法的偵測極限依序E2為8 pg;2-OHE2和4-OHE2皆為4 pg。而在酵素反應實驗,我們偵測到在肝臟中,公鼠與母鼠對照組部分E2 2-hydroxylase活性分別為107.5與35.0 pmol/min/mg而E2 4-hydroxylase之酵素活性分別為1.3與0.4 pmol/min/mg;經過B[a]P處理過後E2 2-hydroxylase酵素活性分別為67.1與24.5 pmol/min/mg而E2 4-hydroxylase之酵素活性分別為1.0與0.3 pmol/min/mg,結果顯示,公大鼠之E2 hydroxylase酵素活性較母鼠高約3倍,另外經B[a]P處理過後公、母大鼠肝臟之E2 hydroxylation活性皆呈現下降的現象。肺臟部分,公鼠與母鼠對照組部分E2 2-hydroxylase酵素活性分別為0.24與0.22 pmol/min/mg,而E2 4-hydroxylase之酵素活性分別為0.03與0.05 pmol/min/mg;經過B[a]P處理過後E2 2-hydroxylase之酵素活性分別增加為0.51與0.46 pmol/min/mg;E2 4-hydroxylase之酵素活性分別增加為0.06與0.073 pmol/min/mg。與肝臟結果不同的是,公母大鼠於肺臟內之酵素活性相似,另一方面經B[a]P處理後2- and 4-E2 hydroxylase活性皆明顯地上升,這顯示B[a]P對於肺臟的腫瘤形成機轉,或許與增加E2 hydroxylation活性的酵素有關。 由於GC/EI-MS靈敏度不足以進行肝、肺與血液中內生性雌激素與其代謝物之分析,因此為了探討經B[a]P氣管灌注處理24小時後是否造成肝、肺與血液中之內生性estrone (E1)、E2與其相關代謝物濃度產生變化,我們在此利用API3000建立經dansyl chloride衍生化之液相層析串聯式質譜儀 (LC/MS/MS)分析方法,以期望經衍生化後能更進一步增加儀器偵測靈敏度,結果顯示經衍生化後E2與其代謝物偵測極限可達5 fg/μL以下,先前文獻所測得之停經期婦女血液內生性E2濃度約為20 fg/μL,因此使用此方法應足以進行分析,有繼續開發下去的價值。

關鍵字

氣管灌注 雌激素

並列摘要


Many studies have pointed out that estrogen and its metabolites (2- and 4-hydroxylated estrogen) involve in the formation of many cancers. Benzo[a]pyrene (B[a]P), an animal carcinogen, is known to increase cytochrome P4501 (CYP1) enzymes activities, which catalyze 17β-estradiol (E2) hydroxylation. In animal studies, B[a]P induced liver and lung tumors formation in female mice. The objective of this thesis was to compare effects of intratracheal instillation of B[a]P on activities of E2 hydroxylation in the liver and the lung of rats. First, we established a gas chromatographic /electron impact-mass spectrometry (GC/EI-MS) analysis method for quantification of E2 and its metabolites (2-OHE2, 4-OHE2). In our analysis method, detection limit for E2 is 8 pg; 2-OHE2 and 4-OHE2 are 4 pg. Rats were intratracheally instilled with 4 mg/kg B[a]P. At 24 weeks later, we utilized E2 as the substrate to quantify activities of E2 2- and 4-hydroxylation in the liver and lung. In the liver, E2 2-hydroxylase activity was higher in male (107.5 pmol/min/mg) than in (35.0 pmol/min/mg) female controls. Similarly, E2 4-hydroxylase activity was higher in male (1.3 pmol/min/mg) than in female (0.4 pmol/min/mg) controls. After B[a]P treatment for 24 hr, E2 2-hydroxylase activities respectively were reduced to 67.1 and 24.5 pmol/min/mg in the livers of male and female rats. Similarly, E2 4-hydroxylase activities were respectively reduced to 1.0 and 0.3 pmol/min/mg in the livers of male and female rats. These results showed that E2 hydroxylase enzyme activity of the male rat were approximately 3 times higher than the female rats. Moreover, treatment with B[a]P reduced E2 hydroxylation activity in the liver. In the lung, there was no gender difference in E2 2- and 4-hydroxylase activities. After B[a]P treatment, both E2 2 and 4-hydroxylase activities were significantly increased in the lung of male and female rats. It implied that B[a]P induced E2 hydroxylase activities might a role in lung carcinogenesis in females. However, the sensitivity of GC/EI-MS is insufficient to quantify the endogenous estrogen and its metabolites in the liver, the lung and the blood. Later, we established a liquid chromatography-mass spectrometry/mass spectrometry (LC/MS/MS) analysis method. E2 and its metabolites were derived by dansyl chloride before analysis. The detection limit was lowered to 5 fg/μL. It is more sensitive than reported in literatures - 20 fg/μL. Therefore, this method should be used for quantifying endogenous estrogen and its metabolites in the future.

並列關鍵字

Intratracheal Instillation estrogen

參考文獻


1. Clemons M., Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001; 344(4): 276-85.
2. Gruber C. J., Tschugguel W., Schneeberger C., Huber J. C. Production and actions of estrogens. N Engl J Med 2002;346(5):340-52.
4. James D. Y., Nancy E. D. Estrogen carcinogenesis in breast cancer. N Engl. J. Med. 2006; 354: 270-282.
5. Ercole C., Krystyna F., Joachim G. L., Eleanor R., Deodutta R. Estrogens as Endogenous Genotoxic Agents—DNA Adducts and Mutations. Journal of the National Cancer Institute Monographs 2000, No. 27: 75-93
6. Newbold R. R., Liehr J. G. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res 2000; 60: 235-237.

延伸閱讀